XML 86 R75.htm IDEA: XBRL DOCUMENT v3.20.2
Segment Reporting - Profits to Income Before Taxes (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Segment Reporting Information [Line Items]        
Profits $ 3,428 $ 2,347 $ 10,784 $ 8,673
Interest income 9 61 48 225
Interest expense (203) (231) (624) (674)
Depreciation and amortization     (2,721) (2,716)
Research and development (3,390) (3,204) (7,721) (7,324)
Restructuring costs (114) (232) (269) (444)
Total segment profits        
Segment Reporting Information [Line Items]        
Profits 8,424 8,168 23,347 22,678
Total segment profits | Pharmaceutical segment        
Segment Reporting Information [Line Items]        
Profits 7,974 7,747 22,010 21,437
Total segment profits | Animal Health segment        
Segment Reporting Information [Line Items]        
Profits 451 423 1,336 1,243
Total segment profits | Other segment        
Segment Reporting Information [Line Items]        
Profits (1) (2) 1 (2)
Other profits        
Segment Reporting Information [Line Items]        
Profits (12) 101 188 226
Unallocated        
Segment Reporting Information [Line Items]        
Interest income 9 61 48 225
Interest expense (203) (231) (624) (674)
Depreciation and amortization (395) (382) (1,173) (1,169)
Research and development (3,272) (3,110) (7,364) (7,045)
Amortization of purchase accounting adjustments (285) (329) (879) (1,105)
Restructuring costs (114) (232) (269) (444)
Other unallocated, net $ (724) $ (1,699) $ (2,490) $ (4,019)